Given the central role of the TGF-β1/Smad3 pathway in promoting hepatic fibrosis through ECM accumulation, these findings support PACs-CFE’s role in attenuating fibrogenic signaling [41,42]. The gene discussed is SMAD3; the disease is Hepatic fibrosis.